You are here:
EPA Transcriptomic Assessment Product (ETAP) for Perfluoro-3-Methoxypropanoic Acid
Citation:
Brennan, A., D. Chang, J. Cowden, S. Davidson-Fritz, J. Dean, M. Devito, J. Ford, L. Everett, A. Harrill, S. Hester, M. Hughes, J. Lambert, L. Lizarraga, R. Mezencev, D. Macmillan, G. Patlewicz, Kristina Chialton, R. Thomas, K. Vitense, L. Wehmas, A. Renyer, S. Auerbach, AND W. Casey. EPA Transcriptomic Assessment Product (ETAP) for Perfluoro-3-Methoxypropanoic Acid. U.S. Environmental Protection Agency, Washington, DC, EPA/600/X-24/066, 2024. https://doi.org/10.23645/epacomptox.25352962
Impact/Purpose:
The data for the report is available in 2 places GEO data https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE260875 and BM2 data - https://doi.org/10.23645/epacomptox.25335844
Description:
The EPA Transcriptomic Assessment Product (ETAP) is a human health assessment that utilizes a standardized short-term in vivo study design and data analysis procedures to develop transcriptomic-based reference values for data poor chemicals. The reference value represents the daily dose of the chemical that would likely be without appreciable risk to human health over a lifetime. This dataset corresponds to the transcriptomic studies on perfluoro-3-methoxypropanoic acid (DTXSID70191136). More information about ETAP is available at: https://www.epa.gov/etap.
URLs/Downloads:
DOI: EPA Transcriptomic Assessment Product (ETAP) for Perfluoro-3-Methoxypropanoic Acid
MOPA ETAP ASSESSMENT.PDF (PDF, 39 pp, 1099 KB, about PDF)